SMS Lifesciences India Ltd

SMS Lifesciences Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

SMS Lifesciences India Ltd

₹ 1,212 -3.84%
10 Jun - close price
smslife.in BSE: 540679 NSE: SMSLIFE
About

Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates[1]

Key Points

Business Overview:[1][2][3]
Company is the demerged entity of SMS Pharmaceuticals Ltd, catering to semi-regulated markets across India, Europe, and Asia with a portfolio of 12 APIs in the GAS and Anti-erectile dysfunction (EDF) therapeutic segment. It does manufacturing of Antiulcerative products, for Indian and global markets and supplies KSMs and Intermediates

Website BSE NSE
  • Market Cap ₹ 367 Cr.
  • Current Price ₹ 1,212
  • High / Low ₹ 1,750 / 765
  • Stock P/E 19.6
  • Book Value ₹ 650
  • Dividend Yield 0.12 %
  • ROCE 11.8 %
  • ROE 10.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • The company has delivered a poor sales growth of 5.74% over past five years.
  • Company has a low return on equity of 6.71% over last 3 years.
  • Dividend payout has been low at 3.73% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
95.66 82.28 81.26 88.29 63.73 74.65 69.26 72.05 89.99 92.55 78.46 84.60 89.11
89.23 73.79 72.99 78.92 61.45 72.11 61.33 62.75 78.63 76.27 69.89 71.85 81.69
Operating Profit 6.43 8.49 8.27 9.37 2.28 2.54 7.93 9.30 11.36 16.28 8.57 12.75 7.42
OPM % 6.72% 10.32% 10.18% 10.61% 3.58% 3.40% 11.45% 12.91% 12.62% 17.59% 10.92% 15.07% 8.33%
6.64 0.31 0.15 0.49 4.81 0.61 0.27 0.58 2.36 0.44 2.04 0.06 2.34
Interest 1.75 1.64 1.68 1.67 1.80 2.18 2.81 2.34 2.84 2.40 2.14 2.14 2.03
Depreciation 2.58 2.59 2.64 2.63 2.92 3.70 3.73 3.73 3.78 3.68 3.76 3.76 3.80
Profit before tax 8.74 4.57 4.10 5.56 2.37 -2.73 1.66 3.81 7.10 10.64 4.71 6.91 3.93
Tax % 7.67% 49.23% 23.66% 31.29% 10.55% 40.29% 126.51% -8.14% 8.73% 33.27% 29.72% 29.81% 11.45%
8.08 2.32 3.12 3.82 2.11 -3.83 -0.44 4.12 6.47 7.10 3.30 4.86 3.48
EPS in Rs 26.79 9.96 9.10 13.20 5.66 -5.95 2.25 14.22 19.52 23.15 15.45 18.09 9.82
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
378 261 266 350 316 306 345
343 235 235 316 287 275 300
Operating Profit 35 25 30 35 29 31 45
OPM % 9% 10% 11% 10% 9% 10% 13%
2 2 2 14 5 4 5
Interest 6 5 5 6 7 10 9
Depreciation 6 8 8 10 11 15 15
Profit before tax 25 15 20 33 17 10 26
Tax % 30% 31% 31% 23% 31% 36% 28%
18 10 14 25 11 6 19
EPS in Rs 59.04 33.67 44.85 83.75 37.91 30.07 66.52
Dividend Payout % 3% 0% 3% 2% 4% 5% 2%
Compounded Sales Growth
10 Years: %
5 Years: 6%
3 Years: -1%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 13%
3 Years: 6%
TTM: 196%
Stock Price CAGR
10 Years: %
5 Years: 30%
3 Years: 20%
1 Year: 53%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 7%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3 3 3 3 3 3 3
Reserves 103 113 126 149 166 174 194
47 65 65 80 100 101 86
116 72 108 125 126 113 107
Total Liabilities 270 253 302 357 395 391 390
118 124 130 142 228 223 232
CWIP 3 16 38 51 1 6 0
Investments 0 0 0 0 0 0 0
148 113 134 164 166 161 158
Total Assets 270 253 302 357 395 391 390

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
30 15 35 -11 15 24 34
-44 -27 -26 -7 -31 -18 -15
15 12 -3 11 17 -7 -19
Net Cash Flow 1 -0 6 -8 0 -1 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 40 30 47 35 53 61 73
Inventory Days 116 149 164 159 184 196 160
Days Payable 140 101 163 146 127 143 126
Cash Conversion Cycle 16 78 48 48 110 115 106
Working Capital Days 27 47 37 56 76 89 78
ROCE % 12% 13% 12% 8% 7% 12%

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
69.85% 69.85% 70.32% 70.32% 70.32% 70.32% 70.68% 71.19% 71.40% 71.40% 71.40% 71.40%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.02% 0.00% 0.00%
30.15% 30.14% 29.69% 29.67% 29.68% 29.68% 29.31% 28.81% 28.59% 28.57% 28.59% 28.60%
No. of Shareholders 8,9398,7998,5938,3498,4758,4438,2338,1167,8617,8497,6267,479

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings